Form 8-K - Current report:
SEC Accession No. 0001193125-24-254200
Filing Date
2024-11-08
Accepted
2024-11-08 16:37:30
Documents
13
Period of Report
2024-11-04
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d882677d8k.htm   iXBRL 8-K 22961
  Complete submission text file 0001193125-24-254200.txt   147451

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tbio-20241104.xsd EX-101.SCH 2505
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbio-20241104_lab.xml EX-101.LAB 18699
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbio-20241104_pre.xml EX-101.PRE 11680
16 EXTRACTED XBRL INSTANCE DOCUMENT d882677d8k_htm.xml XML 3885
Mailing Address 10431 WATERIDGE CIRCLE SUITE 150 SAN DIEGO CA 92121
Business Address 10431 WATERIDGE CIRCLE SUITE 150 SAN DIEGO CA 92121 858-228-4115
Telesis Bio Inc. (Filer) CIK: 0001850079 (see all company filings)

EIN.: 451216839 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40497 | Film No.: 241441281
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)